- RU-58841 has never completed a human clinical trial as of October 2026.
- Battmann et al. (1994, PMID 8136306) showed potent local antiandrogen activity in rodent models.
- De Brouwer et al. (1997, PMID 9415227) reported RU-58841 improved regrowth of human follicles grafted onto mice versus vehicle.
- Pan and Uno (1998, PMID 9798729) reported regrowth in the stump-tailed macaque model.
- Roussel-Uclaf shelved RU-58841 in the 1990s for commercial reasons before any Phase 3 programme ran.
- Community reports span 15 or more years but are uncontrolled and cannot establish efficacy in humans.
- RU58841 has never completed a human clinical trial. That is the single most important fact and it changes how you should think about every other data point.
- What does exist: controlled animal research from the 1990s (macaque, mouse-grafted human follicle) plus 15+ years of anecdotal community reports.
- The animal data is genuine and shows a real effect at the receptor. The human evidence is anecdotal.
- "Does it work?" is not the same question as "is there evidence?" and honest sources should not conflate them.
The honest short answer
RU58841 has a real mechanism (blocking DHT at the androgen receptor), controlled animal research showing that mechanism produces measurable hair regrowth in relevant models, and more than a decade of community use with mixed but broadly positive anecdotal reports. What it does not have, and has never had, is a completed human clinical trial. Anyone telling you it definitively works is going beyond what the evidence actually supports. Anyone telling you it definitively does not work is doing the same in the opposite direction.
What the animal research actually showed
The single most-cited RU58841 study is Uno et al., 1998, which used the stump-tailed macaque model of androgenetic alopecia (stump-tailed macaques develop pattern hair loss in a way that mirrors the human condition closely). Topical RU58841 produced statistically significant hair regrowth compared to vehicle. This is not a trivial study. It is a genuine controlled experiment in the most relevant animal model available.
The other important body of work is the mouse-grafted follicle studies: researchers took human scalp follicles from balding donors, grafted them onto testosterone-conditioned mice, and treated them topically. RU58841 improved outcomes over vehicle. This is not a mouse growing human hair out of nowhere; it is a controlled way to test the compound against actual human follicles under conditions similar to what happens on a human scalp.
What is missing
Human clinical trials. The kind of large, controlled, placebo-blinded studies that turn "promising" into "proven." RU58841 never went through this stage because Roussel-Uclaf shelved the compound in the 1990s for commercial reasons, not scientific ones. Nobody has funded the trials since. That is why every honest summary has to say research compound, not proven treatment.
What the community reports show
Fifteen years of use, thousands of self-reports, and a substantial body of photographic evidence. The dominant pattern in these reports is "modest to moderate improvement in maintenance and some regrowth over 6 to 12 months of consistent use." That is real signal. It is not evidence-grade data, because:
- Selection bias: people who see results post; people who see nothing quietly move on.
- Confounders: most users run RU alongside finasteride, minoxidil, or both. Isolating the RU contribution is impossible from anecdotes.
- Placebo effects and photo variance: hair loss is slow and visual, lighting and angle change apparent results dramatically.
How to think about "does it work"
The evidence-grade answer is: the mechanism is real, the animal data is supportive, the human data is anecdotal but consistent, and no trial has confirmed it in humans. That is a fundamentally different answer from either "yes it works" or "no it doesn't." How you weigh those inputs is a decision for the individual researcher.
Norwood Labs publishes sample reports from a third-party analytical laboratory. Those reports document the samples named in them, not every bottle shipped. What happens in your research after that is not something any supplier can honestly guarantee, and we won't pretend otherwise.